|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wolfgang M. Baiker, Corporate Head of Development, Boehringer Ingelheim
|
|
|
|
James Bailey, GSK Team Leader, Medicinal Chemsitry, GSK
|
|
|
|
Sophie Banzet, Head of Safety Science CNS, Roche
|
|
|
|
Mireille Cantarini, Internal Clinical genetics Expert, Astrazeneca
|
|
|
|
Annick Cauvin, Senior Principal Scientist, Toxicology, UCB
|
|
|
|
Gvido Cebers, Principal Scientist, CNSP Research Area Toxicologist, Global Safety Assessment, Astrazeneca
|
|
|
|
Dominique, Demolle, CEO, Aepodia
|
|
|
|
Lucette Doessegger, Global Head Safety Licensing and Early Development, Roche
|
|
|
|
Martin Elmlinger, Director Biomarkers, Nycomed
|
|
|
|
Angela, Flannery Director, R&D Science Policy, Astrazeneca
|
|
|
|
Dr. Thomas Herget, Senior Director R&D New Technology Evaluation Performance & Life Science Chemicals, Merck
|
|
|
|
Vicki Ikin, Clinical Biomarker Scientist Group Manager, Astrazeneca
|
|
|
|
Bahija Jallal, VP Translational Sciences, Medimmune
|
|
|
|
Jörg Kemkowski, Vice President, Head of Institute of Pharmcology and Preclinical Drug Safety (IPAS), Nycomed GmbH
|
|
|
|
Farhad Khan, Principal Scientist in Epidemiology, Novo Nordisk A/S
|
|
|
|
Michael, L. Lim, PharmD, Oncology Medicine Development Centre,
|
|
|
|
Roy Mansfield, Director Safety and Risk Management, Pfizer
|
|
|
|
Dr. Julian C. Matthews, Senior Lecturer in the School of Cancer and Imaging Sciences, University of Manchester
|
|
|
|
Howard Mellor, Pre-Clinical Safety Scientist, General Toxicology Sciences, Safety Assessment UK, Astrazeneca
|
|
|
|
Alan, Morrison VP International Regulatory Affairs, Amgen
|
|
|
|
David Nicholson, SVP Global Research, Schering Plough
|
|
|
|
Michael O'Connell, Director, Life Sciences, Clinical Practice, Spotfire, TIBCO Software INC.
|
|
|
|
Taoufik Outas, Senior Scientist - Exploratory Development Department, Astellas
|
|
|
|
Elke Persohn, Head of Cellular Imaging Group, Novartis
|
|
|
|
Stefan Platz, Head Toxicology and Global Head Early Safety, Hoffman la Roche
|
|
|
|
Marc Princivalle, Director of Toxicology, Research and Preclinical Development & Head of Preclinical Rish Assessment, EMEA, Stiefel (GSK)
|
|
|
|
Eugenii Rabiner, Director, Clinical Imaging Applications, GSK
|
|
|
|
Tino Rossi, VP Preclinical Drug Discovery & Enabling Technologies, Neurosciences CEDD, GlaxoSmithKline
|
|
|
|
Thomas Steinbach, Senior Director Safety Surveillance & Risk Management, Wyeth
|
|
|
|
Philippe Van der Auwera, Global Head of Safety, Roche
|
|
|
|
Jingsong Wang, Director Discovery Medicine & Clinical Pharmacology, Bristol Myers Squibb
|
|
|
|
Will Watson, Senior Partnering Director, Teva Innovative ventures
|
|
|
|
Agnes Westelinck. Regulatory Affairs, Roche
|
|
|
|
|
|
|
|
Speakers
